New Vernon Capital Holdings Ii LLC Ironwood Pharmaceuticals Inc Transaction History

New Vernon Capital Holdings Ii LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.58 - $8.61 $172,260 - $265,799	-30,871 Reduced 58.87%	21,572 $140,000
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $182,287 - $238,694	20,738 Added 65.41%	52,443 $599,000
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $39,905 - $54,899	4,837 Added 18.0%	31,705 $305,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $53,489 - $61,433	5,296 Added 24.55%	26,868 $285,000
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $1,731 - $2,097	167 Added 0.78%	21,572 $226,000
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $34,412 - $43,206	3,476 Added 19.39%	21,405 $265,000
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $137,457 - $167,823	-13,556 Reduced 43.06%	17,929 $186,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $347,909 - $400,489	31,485 New	31,485 $363,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.